Motley Fool  3 hrs ago  Comment 
The Fed thinks biotech stocks are overvalued. Here's where they're wrong.  Jul 18  Comment 
WASHINGTON (dpa-AFX) - Following the sell-off seen in the previous session, stocks showed a strong move back to the upside over the course of the trading day on Friday. The Dow nearly offset yesterday's steep loss but still finished below the...
Benzinga  Jul 18  Comment 
Biotech stock stocks enter their earnings season with investors increasingly interested in the long-term outlook for product pipelines, although large-cap growth stocks remain central to the sectors performance, an analyst said Friday. Credit...
Yahoo  Jul 18  Comment 
Did Fed Chair Janet Yellen catch something biotech's top analyst missed? The sector's top analyst isn't buying it.  Jul 18  Comment 
BOSTON (TheStreet) -- Welcome back to the Biotech Stock Mailbag. @adamfeuerstein if possible can you share ur thoughts on ACRX into July27 PDUFA. Haven't seen your article on it. thx — Mario Stockguy (@fireworkstrades) July 11, 2014 Unless...
FierceBiotech  Jul 18  Comment 
Biotechs raked in a whopping $1.8 billion in venture cash last quarter, the industry's biggest haul since PricewaterhouseCoopers and the National Venture Capital Association started keeping track in 1995.
Forbes  Jul 17  Comment 
On Tuesday Janet Yellen, the chair of the Federal Reserve, made comments indicating that biotechnology stocks were oversold. Since then, the Nasdaq iShares Biotechnology Index has dropped 4%. I got the following comment via email from Robert...
Forbes  Jul 17  Comment 
Capital efficiency has become a mantra at Atlas, one shared by a number of other early stage biotech investors. It's a term often repeated in discussions about building young companies, and yet it has become clear that there’s no consistent...
Jutia Group  Jul 17  Comment 
The Life Sciences Report: Alan, at BioWatch News you present investment ideas to your subscribers, bringing a "venture analyst's approach" to the due diligence process as you evaluate companies. What does that mean? Do you perform ground-up,...
The Hindu Business Line  Jul 17  Comment 
A Sydney-based biotechnology company NeuClone has inked a licensing agreement and joint development partnership with Serum Institute of India to manufacture and supply 10 biosimilar monoclonal ant...


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki